キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/06/24 | 3,185 | 3,185 | 3,135 | 3,165 | -10 | -0.3% | 71,100 |
2024/06/21 | 3,195 | 3,205 | 3,165 | 3,175 | +5 | +0.2% | 86,900 |
2024/06/20 | 3,180 | 3,200 | 3,160 | 3,170 | -10 | -0.3% | 31,100 |
2024/06/19 | 3,190 | 3,195 | 3,170 | 3,180 | -5 | -0.2% | 17,800 |
2024/06/18 | 3,155 | 3,185 | 3,140 | 3,185 | +40 | +1.3% | 25,500 |
2024/06/17 | 3,110 | 3,145 | 3,075 | 3,145 | ±0 | ±0% | 37,900 |
2024/06/14 | 3,100 | 3,160 | 3,070 | 3,145 | +45 | +1.5% | 73,300 |
2024/06/13 | 3,150 | 3,150 | 3,075 | 3,100 | -50 | -1.6% | 36,800 |
2024/06/12 | 3,130 | 3,160 | 3,130 | 3,150 | -10 | -0.3% | 24,800 |
2024/06/11 | 3,230 | 3,240 | 3,150 | 3,160 | -55 | -1.7% | 35,400 |
2024/06/10 | 3,170 | 3,230 | 3,170 | 3,215 | +50 | +1.6% | 61,200 |
2024/06/07 | 3,160 | 3,175 | 3,140 | 3,165 | ±0 | ±0% | 32,200 |
2024/06/06 | 3,165 | 3,175 | 3,110 | 3,165 | +5 | +0.2% | 70,800 |
2024/06/05 | 3,125 | 3,165 | 3,120 | 3,160 | -35 | -1.1% | 51,400 |
2024/06/04 | 3,205 | 3,240 | 3,190 | 3,195 | -5 | -0.2% | 71,600 |
2024/06/03 | 3,165 | 3,215 | 3,155 | 3,200 | +55 | +1.7% | 92,100 |
2024/05/31 | 3,065 | 3,150 | 3,065 | 3,145 | +95 | +3.1% | 208,200 |
2024/05/30 | 3,010 | 3,070 | 3,000 | 3,050 | +15 | +0.5% | 116,500 |
2024/05/29 | 3,055 | 3,070 | 3,020 | 3,035 | -20 | -0.7% | 63,300 |
2024/05/28 | 3,130 | 3,130 | 3,055 | 3,055 | -80 | -2.6% | 92,700 |
2024/05/27 | 3,190 | 3,190 | 3,120 | 3,135 | -70 | -2.2% | 109,100 |
2024/05/24 | 3,150 | 3,220 | 3,150 | 3,205 | +55 | +1.7% | 138,000 |
2024/05/23 | 3,090 | 3,155 | 3,090 | 3,150 | +80 | +2.6% | 65,400 |
2024/05/22 | 3,130 | 3,155 | 3,070 | 3,070 | -55 | -1.8% | 59,800 |
2024/05/21 | 3,165 | 3,175 | 3,125 | 3,125 | -35 | -1.1% | 58,800 |
2024/05/20 | 3,140 | 3,180 | 3,140 | 3,160 | ±0 | ±0% | 61,300 |
2024/05/17 | 3,140 | 3,170 | 3,110 | 3,160 | +20 | +0.6% | 47,200 |
2024/05/16 | 3,105 | 3,150 | 3,100 | 3,140 | +20 | +0.6% | 65,400 |
2024/05/15 | 3,150 | 3,155 | 3,095 | 3,120 | -30 | -1% | 93,300 |
2024/05/14 | 3,150 | 3,170 | 3,120 | 3,150 | +20 | +0.6% | 76,200 |
2024/05/13 | 3,175 | 3,175 | 3,105 | 3,130 | -55 | -1.7% | 125,400 |
2024/05/10 | 3,200 | 3,225 | 3,180 | 3,185 | -35 | -1.1% | 120,800 |
2024/05/09 | 3,235 | 3,260 | 3,200 | 3,220 | -10 | -0.3% | 254,500 |
2024/05/08 | 3,300 | 3,330 | 3,220 | 3,230 | -420 | -11.5% | 393,400 |
2024/05/07 | 3,690 | 3,700 | 3,630 | 3,650 | -5 | -0.1% | 103,600 |
2024/05/02 | 3,645 | 3,655 | 3,610 | 3,655 | +60 | +1.7% | 35,600 |
2024/05/01 | 3,595 | 3,625 | 3,570 | 3,595 | -30 | -0.8% | 37,800 |
2024/04/30 | 3,605 | 3,630 | 3,560 | 3,625 | +40 | +1.1% | 47,400 |
2024/04/26 | 3,525 | 3,605 | 3,465 | 3,585 | +50 | +1.4% | 94,700 |
2024/04/25 | 3,545 | 3,580 | 3,525 | 3,535 | -40 | -1.1% | 54,900 |
2024/04/24 | 3,600 | 3,600 | 3,550 | 3,575 | +5 | +0.1% | 55,200 |
2024/04/23 | 3,480 | 3,570 | 3,480 | 3,570 | +45 | +1.3% | 39,200 |
2024/04/22 | 3,490 | 3,540 | 3,475 | 3,525 | +105 | +3.1% | 59,300 |
2024/04/19 | 3,445 | 3,470 | 3,385 | 3,420 | -55 | -1.6% | 59,800 |
2024/04/18 | 3,510 | 3,525 | 3,440 | 3,475 | -50 | -1.4% | 46,900 |
2024/04/17 | 3,580 | 3,600 | 3,505 | 3,525 | -90 | -2.5% | 64,200 |
2024/04/16 | 3,620 | 3,640 | 3,595 | 3,615 | -40 | -1.1% | 65,800 |
2024/04/15 | 3,605 | 3,675 | 3,605 | 3,655 | +40 | +1.1% | 77,000 |
2024/04/12 | 3,590 | 3,625 | 3,590 | 3,615 | +35 | +1% | 72,500 |
2024/04/11 | 3,500 | 3,585 | 3,495 | 3,580 | +50 | +1.4% | 75,400 |
301~
350
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム